Health

Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies at APHRS and JPHRS

Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes. YOKOHAMA, Japan, Nov. 3, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment1, today announced th...

2025-11-03 14:35 1069

Sandstone Easydrip™ Plus with Hextra Tech™ Hexagonal Broad Hub Delivers Steadier, More Comfortable Insulin Injections

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- A peer-reviewed article by researchers at the University ofShanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ hexagonal, broad-platform hub used in Sandstone Easydrip™ Plus ...

2025-11-03 14:35 889

Biomom Reinvents "Snow" with Five-Layer Safety Packaging -- Stronger Protection and Greater Convenience for Kids' Probiotics

SEOUL, South Korea, Nov. 3, 2025 /PRNewswire/ -- Health supplement brand Biomom has introduced upgraded, hygienic packaging for its flagship probiotic "Biomom Snow." The renewal features five-layer safety stick and pillow packaging designed to enhance probiotic protection and ensure a more conve...

2025-11-03 14:00 787

MALAYSIA HEALTHCARE TRAVEL COUNCIL STRENGHTENS REGIONAL PRESENCE IN MEDAN THROUGH ASTINDO TRAVEL FAIR 2025

MEDAN, Indonesia, Nov. 3, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) continues to advance its regional outreach by participating in the ASTINDO Travel Fair (ATF) 2025, held inMedan, Indonesia. The event serves as one of the largest tourism exhibitions in the country, gathe...

2025-11-03 11:37 1038

OMANI PATIENTS GAIN DIRECT ACCESS TO MALAYSIAN MEDICAL SPECIALISTS THROUGH WEEK-LONG HEALTHCARE ACTIVATION

SEEB, Oman, Nov. 3, 2025 /PRNewswire/ -- Malaysia Healthcare Week opens at City Centre Mall, Seeb, marking the first majorMiddle East activation under the Malaysia Year of Medical Tourism (MYMT) 2026. The week-long programme connects Omani patients with Malaysian medical specialists through publi...

2025-11-03 11:19 1136

Oxford Instruments introduces the witec360 Raman Microscope with Hexalight Spectrometer to advance research in Singapore and across Southeast Asia

LONDON, Nov. 3, 2025 /PRNewswire/ -- Oxford Instruments today announced the launch of its witec360Raman microscope with the Hexalight spectrometer, setting a new benchmark in confocal Raman imaging and analysis. The new system delivers unprecedented optical performance, automation, and flexibilit...

2025-11-03 09:00 1137

Caregility and MOD3RN Care Partner to Modernise Healthcare Delivery in Australia

WALL, N.J. and BARANGAROO, Australia, Nov. 3, 2025 /PRNewswire/ -- Caregility Corporation, a global enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere through innovative virtual care and AI-powered solutions, today announced a strategic reseller partn...

2025-11-03 05:30 1126

Bio Farma Indonesia Leads Global Vaccine Manufacturers as Host of the 26th DCVMN AGM in Bali

BALI, Indonesia, Oct. 31, 2025 /PRNewswire/ -- Bali, October 29, 2025, Indonesia , throughBio Farma, is hosting the 26th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers Network (DCVMN) inBali on October 29–31, 2025.  The forum brings together vaccine manufacturers, ...

2025-10-31 20:01 2451

Elevaris Medical Devices Names New Chief Engineering and Operations Officer

BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies, announced the appointment of its new Chief Engineering and Operations Officer,Salvador Montes.

2025-10-31 20:00 1148

Kexing Biopharm Showcases Global Strategy and Partnership Opportunities at CPHI Frankfurt 2025

FRANKFURT, Germany, Oct. 31, 2025 /PRNewswire/ -- From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international commercialization solutions to partners from glo...

2025-10-31 19:50 1598

AXA BetterMe Weekend Celebrates Its 5th Anniversary with over 13,000 participants

Spreading positivity across the city and inspiring everyone to achieve their BetterMe HONG KONG, Oct. 31, 2025 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") successfully concluded its annual community carnival, the "AXA BetterMe Weekend ", held from 25 to 26 October atAXA WONDERLAND, WestK. Cel...

2025-10-31 18:04 1292

JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential

SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an Amendment to its strategic collaboration agreement with R...

2025-10-31 17:38 1143

Xinhua Silk Road: Chinese biz leaders hold talks to explore cultural inheritance, innovation

BEIJING, Oct. 31, 2025 /PRNewswire/ -- On Tuesday, an in-depth talk between board chairmen of Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang) and Kweichow Moutai Group highlighted joint effort to promote inheritance and innovation of traditional Chinese culture. After discussi...

2025-10-31 16:15 855

Catalent Debuts New Corporate Brand, Elevating Customer Service Excellence by "Championing the Missions that Matter™"

TAMPA, Fla., Oct. 31, 2025 /PRNewswire/ -- Catalent, Inc., a leading global contract development and manufacturing organization, today unveiled its new corporate brand, marking a strategic evolution that underscores the company's commitment to delivering unparalleled customer service and its focu...

2025-10-31 08:30 1043

Singapore Court Confirms GNC's Rights to Assume Former GNC Store Leases from LAC, Setting the Stage for Continued Growth in Singapore

Ruling reduces market confusion and reinforces GNC's science‑backed leadership; company accelerates partnership with Watsons to deliver best‑in‑class wellness solutions for consumers PITTSBURGH, Oct. 31, 2025 /PRNewswire/ -- GNC

2025-10-31 07:00 1310

IMG Wins Two 2025 Travel Weekly Magellan Awards

INDIANAPOLIS, Oct. 30, 2025 /PRNewswire/ -- IMG (International Medical Group) has been recognized with twoTravel Weekly Magellan Awards

2025-10-30 21:00 924

NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries

* NovaBridge subsidiary Visara assigned its exclusive license to Everest Medicines to accelerate the development of potential best-in-class therapy for wet AMD, VIS-101, leveraging Everest Medicines' strong clinical and commercialization expertise inGreater China and other Asian markets * Nov...

2025-10-30 16:15 1052

Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders

* Everest Medicines acquired an exclusive license to develop, manufacture, and commercialize VIS-101 inGreater China, Singapore, South Korea, and certain Southeast Asian countries. * Under the assigned exclusive license, Everest Medicines will make an upfront payment ofUS$7 million (equivalen...

2025-10-30 11:05 1234

LOTTE BIOLOGICS and SK pharmteco Sign Strategic Partnership to Strengthen Global ADC CDMO Capabilities

* Two global CDMO leaders have joined forces to strengthen their presence in the rapidly growing antibody-drug conjugate (ADC) market. * The collaboration will deliver integrated, one-stop CDMO services spanning antibody drug substance, linker–payload production, and bioconjugation, supported...

2025-10-30 09:15 1203

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announcedthe initiation of a Phase II clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial virus (RSV) infection. Building on ArkBio's previous experi...

2025-10-30 09:00 1214
1 ... 11121314151617 ... 561